Pharmacogenetics of efavirenz discontinuation for reported central nervous system symptoms appears to differ by race-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacogenetics of efavirenz discontinuation for reported central nervous system symptoms appears to differ by race

Published:2016-10 Issue:10 Volume:26 Page:473-480
ISSN:1744-6872
Container-title:Pharmacogenetics and Genomics
language:en
Short-container-title:

Author:

Leger Paul,Chirwa Sanika,Turner Megan,Richardson Danielle M.,Baker Paxton,Leonard Michael,Erdem Husamettin,Olson Lana,Haas David W.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics

Reference41 articles.

1. Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study;Van Leth;Lancet,2004

2. Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial;Gulick;JAMA,2006

3. Class-sparing regimens for initial treatment of HIV-1 infection;Riddler;N Engl J Med,2008

4. Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial;Lennox;Lancet,2009

5. Maraviroc versus efavirenz, both in combination with zidovudine-lamivudine, for the treatment of antiretroviral-naive subjects with CCR5-tropic HIV-1 infection;Cooper;J Infect Dis,2010

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of dolutegravir-associated weight gain and secondary metabolic comorbidities;SAGE Open Medicine;2024-01

2. The influence of single nucleotide polymorphisms on the therapeutic effect of antiretroviral drugs;Medicinski podmladak;2024

3. Pharmacogenetics of weight gain following switch from efavirenz- to integrase inhibitor-containing regimens;Pharmacogenetics and Genomics;2023-11-01

4. Associations between efavirenz concentrations, pharmacogenetics and neurocognitive performance in people living with HIV in Nigeria;AIDS;2021-06-09

5. Association between cigarette smoking and plasma concentration of efavirenz: a systematic review;HIV & AIDS Review;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3